{"id":"https://openalex.org/W4386086608","doi":"https://doi.org/10.1093/oncolo/oyad216.024","title":"Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies","display_name":"Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies","publication_year":2023,"publication_date":"2023-08-23","ids":{"openalex":"https://openalex.org/W4386086608","doi":"https://doi.org/10.1093/oncolo/oyad216.024"},"language":"en","primary_location":{"id":"doi:10.1093/oncolo/oyad216.024","doi":"https://doi.org/10.1093/oncolo/oyad216.024","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyad216.024","pdf_url":"https://academic.oup.com/oncolo/article-pdf/28/Supplement_1/S14/51234226/oyad216.024.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/oncolo/article-pdf/28/Supplement_1/S14/51234226/oyad216.024.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007689146","display_name":"Eric W. Jonasch","orcid":"https://orcid.org/0000-0003-0943-2806","observed_orcids":["https://orcid.org/0000-0003-0943-2806"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jonasch","raw_affiliation_strings":["University of Texas MD Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053257668","display_name":"Justin Call","orcid":"https://orcid.org/0000-0001-8227-7406","observed_orcids":["https://orcid.org/0000-0001-8227-7406"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justin Call","raw_affiliation_strings":["START Mountain Region"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"START Mountain Region","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012169173","display_name":"Swetha Kambhampati","orcid":"https://orcid.org/0000-0002-4783-2643","observed_orcids":["https://orcid.org/0000-0002-4783-2643","https://orcid.org/0000-0002-5776-3274"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swetha Kambhampati","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016048836","display_name":"Paolo Fabrizio Caimi","orcid":"https://orcid.org/0000-0003-1436-0464","observed_orcids":["https://orcid.org/0000-0003-1436-0464"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paolo Caimi","raw_affiliation_strings":["Cleveland Clinic Foundation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029588412","display_name":"Brendan D. Curti","orcid":"https://orcid.org/0000-0003-3948-2708","observed_orcids":["https://orcid.org/0000-0003-3948-2708"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brendan Curti","raw_affiliation_strings":["Providence Cancer Institute, Providence Portland Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Cancer Institute, Providence Portland Medical Center","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014995908","display_name":"Catherine Diefenbach","orcid":"https://orcid.org/0000-0003-1116-3246","observed_orcids":["https://orcid.org/0000-0003-1116-3246"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Diefenbach","raw_affiliation_strings":["NYU Langone Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Health","institution_ids":["https://openalex.org/I4210086933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000198604","display_name":"Elisabeth I. Heath","orcid":"https://orcid.org/0000-0003-1381-2713","observed_orcids":["https://orcid.org/0000-0003-1381-2713"]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elisabeth Heath","raw_affiliation_strings":["Barbara Ann Karmanos Cancer Institute - Hudson-Webber Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Ann Karmanos Cancer Institute - Hudson-Webber Cancer Research Center","institution_ids":["https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070252326","display_name":"Steven I. Park","orcid":"https://orcid.org/0000-0001-5674-6408","observed_orcids":["https://orcid.org/0000-0001-5674-6408"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Park","raw_affiliation_strings":["Levine Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Levine Cancer Institute","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061052702","display_name":"Noah Saul Kornblum","orcid":"https://orcid.org/0000-0001-5985-2011","observed_orcids":["https://orcid.org/0000-0001-5985-2011"]},"institutions":[{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah Kornblum","raw_affiliation_strings":["Montefiore Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montefiore Medical Center","institution_ids":["https://openalex.org/I1335289525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100369270","display_name":"Weidong Li","orcid":"https://orcid.org/0000-0001-5384-4838","observed_orcids":["https://orcid.org/0000-0001-5384-4838","https://orcid.org/0009-0005-9524-7296"]},"institutions":[{"id":"https://openalex.org/I4210153921","display_name":"Guangzhou Medical University Cancer Hospital","ror":"https://ror.org/046c18a90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153921"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weidong Li","raw_affiliation_strings":["Affiliated Cancer Hospital and Institute of Guangzhou Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Affiliated Cancer Hospital and Institute of Guangzhou Medical University","institution_ids":["https://openalex.org/I4210153921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033671689","display_name":"Melissa Andrea Reimers","orcid":"https://orcid.org/0000-0002-5167-3630","observed_orcids":["https://orcid.org/0000-0002-5167-3630"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Reimers","raw_affiliation_strings":["Washington University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003766253","display_name":"Stephen E. F. Spurgeon","orcid":"https://orcid.org/0000-0001-9962-438X","observed_orcids":["https://orcid.org/0000-0001-9962-438X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Spurgeon","raw_affiliation_strings":["Oregon Health Sciences University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health Sciences University","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073593424","display_name":"Ulka N. Vaishampayan","orcid":"https://orcid.org/0000-0001-5800-4571","observed_orcids":["https://orcid.org/0000-0001-5800-4571"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ulka Vaishampayan","raw_affiliation_strings":["University of Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101763455","display_name":"Dingwei Ye","orcid":"https://orcid.org/0000-0002-5683-0260","observed_orcids":["https://orcid.org/0000-0002-5683-0260"]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]},{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dingwei Ye","raw_affiliation_strings":["Fudan University Shanghai Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fudan University Shanghai Cancer Hospital","institution_ids":["https://openalex.org/I24943067","https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425464","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0001-8719-4407","observed_orcids":["https://orcid.org/0000-0001-8719-4407"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":["Sun Yat-sen University Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun Yat-sen University Cancer Center","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069739901","display_name":"Weili Zhao","orcid":"https://orcid.org/0000-0002-6834-1616","observed_orcids":["https://orcid.org/0000-0002-6834-1616"]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weili Zhao","raw_affiliation_strings":["Ruijin Hospital-Shanghai Jiaotong University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ruijin Hospital-Shanghai Jiaotong University School of Medicine","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2801556517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100449751","display_name":"Zhu Chen","orcid":"https://orcid.org/0000-0002-9974-0716","observed_orcids":["https://orcid.org/0000-0002-9974-0716","https://orcid.org/0000-0001-8827-3342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhu Chen","raw_affiliation_strings":["ProfoundBio US Co. , Woodinville, WA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co. , Woodinville, WA , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067778266","display_name":"Naomi N. H. Hunder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naomi Hunder","raw_affiliation_strings":["ProfoundBio US Co. , Woodinville, WA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co. , Woodinville, WA , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009784472","display_name":"Sharon Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Ma","raw_affiliation_strings":["ProfoundBio US Co. , Woodinville, WA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co. , Woodinville, WA , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Song","raw_affiliation_strings":["ProfoundBio US Co. , Woodinville, WA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProfoundBio US Co. , Woodinville, WA , USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002887876","display_name":"Benjamin Garmezy","orcid":"https://orcid.org/0000-0003-2790-6235","observed_orcids":["https://orcid.org/0000-0003-2790-6235"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Garmezy","raw_affiliation_strings":["Sarah Cannon Research Institute at Tennessee Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute at Tennessee Oncology","institution_ids":["https://openalex.org/I4210135086"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3494,"currency":"USD","value_usd":3494},"apc_paid":{"value":3494,"currency":"USD","value_usd":3494},"fwci":0.4946,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.58479228,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"28","issue":"Supplement_1","first_page":"S14","last_page":"S15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9380000233650208,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9380000233650208,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd70","display_name":"CD70","score":0.7919999957084656},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9929999709129333},{"id":"https://openalex.org/keywords/exatecan","display_name":"exatecan","score":0.9909999966621399},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/hydrophilic-linkers","display_name":"hydrophilic linkers","score":0.8999999761581421},{"id":"https://openalex.org/keywords/protease-cleavable-linker","display_name":"protease-cleavable linker","score":0.9070000052452087},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7990000247955322},{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.800000011920929},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7400000095367432},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8740000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9909999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7234218716621399},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5219435095787048},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4956852197647095},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4936178922653198},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4872680902481079},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48470163345336914},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4700899124145508},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.43894442915916443},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.4275636076927185},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3269537687301636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3030809760093689},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2706449031829834},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.222642719745636}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/oncolo/oyad216.024","doi":"https://doi.org/10.1093/oncolo/oyad216.024","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyad216.024","pdf_url":"https://academic.oup.com/oncolo/article-pdf/28/Supplement_1/S14/51234226/oyad216.024.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10445573","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10445573","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10445573/pdf/oyad216.024.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/oncolo/oyad216.024","doi":"https://doi.org/10.1093/oncolo/oyad216.024","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyad216.024","pdf_url":"https://academic.oup.com/oncolo/article-pdf/28/Supplement_1/S14/51234226/oyad216.024.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4119534169","display_name":null,"funder_award_id":"W81XWH","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386086608.pdf","grobid_xml":"https://content.openalex.org/works/W4386086608.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388047904","https://openalex.org/W4282970098","https://openalex.org/W4282969264","https://openalex.org/W4365512287","https://openalex.org/W4388070826","https://openalex.org/W4379282892","https://openalex.org/W4393075770","https://openalex.org/W4282927991","https://openalex.org/W4362534529","https://openalex.org/W2502060432"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"PRO1160":[2,32,120,140,165,226,286,324],"is":[3,17,77,91,98,102,121,166,209,287,384],"a":[4,35,43,51,71,104,182,296],"novel":[5],"antibody-drug":[6],"conjugate":[7],"(ADC)":[8],"directed":[9],"to":[10,79,216,269,317,326],"CD70,":[11,41],"an":[12,210],"antigen":[13],"mediating":[14],"immuno-suppression":[15],"that":[16,59],"overexpressed":[18],"in":[19,29,94,124,146,168,179,186,194,227,250,283,389,395],"multiple":[20],"solid":[21],"tumors":[22],"and":[23,48,67,76,101,116,136,160,170,197,205,222,299,321,325,334,349,352,375],"hematologic":[24],"malignancies,":[25],"with":[26,202,229,392],"limited":[27],"distribution":[28],"normal":[30],"tissues.":[31],"comprises":[33],"(1)":[34],"human":[36],"monoclonal":[37],"antibody":[38,178],"specific":[39],"for":[40,86,259,311],"(2)":[42],"protease-cleavable":[44],"proprietary":[45],"hydrophilic":[46,61],"linker,":[47],"(3)":[49],"exatecan,":[50],"topoisomerase":[52],"1":[53,294],"inhibitor.":[54],"Comprehensive":[55],"prior":[56],"work":[57],"demonstrated":[58],"the":[60,176,189,195,218,246,256,278,284,319,328,371,390],"linker":[62],"confers":[63],"excellent":[64],"physicochemical":[65],"properties":[66],"pharmacokinetics":[68],"(PK)":[69],"across":[70],"range":[72],"of":[73,106,128,150,225,295,323,343],"payload":[74],"mechanisms":[75],"superior":[78],"conventional":[80],"linkers":[81],"on":[82,292],"these":[83],"critical":[84],"parameters":[85],"ADCs.":[87],"In":[88,181],"addition,":[89],"exatecan":[90,203],"broadly":[92],"active":[93],"many":[95],"tumor":[96,152],"types,":[97],"membrane":[99],"permeable,":[100],"not":[103,281],"substrate":[105],"multidrug":[107],"resistance":[108],"pumps,":[109],"thus":[110],"likely":[111],"lending":[112],"strong":[113],"bystander":[114],"effects":[115],"durable":[117],"treatment":[118,300],"responses.":[119],"highly":[122],"potent":[123],"cell-derived":[125],"xenograft":[126,148],"models":[127,149],"renal":[129],"cell":[130],"carcinoma":[131,138],"(RCC),":[132],"non-Hodgkin":[133],"lymphoma":[134],"(NHL),":[135],"nasopharyngeal":[137],"(NPC).":[139],"also":[141,263,379],"demonstrates":[142],"marked":[143],"antitumor":[144,223,376],"activity":[145,224,377],"patient-derived":[147],"diverse":[151],"sites,":[153],"histologies,":[154],"molecular":[155],"subtypes,":[156],"target":[157],"expression":[158],"levels,":[159],"Epstein":[161],"Barr":[162],"Virus":[163],"status.":[164],"stable":[167],"circulation":[169],"displays":[171],"PK":[172],"characteristics":[173],"indistinguishable":[174],"from":[175],"parent":[177],"rats.":[180],"GLP":[183],"toxicity":[184,192],"study":[185,215,341,383],"cynomolgus":[187],"monkeys,":[188],"primary":[190,314],"PRO1160-related":[191],"resided":[193],"thymus":[196],"bone":[198],"marrow,":[199],"was":[200,206],"consistent":[201],"toxicities,":[204],"reversible.":[207],"PRO1160-001":[208],"ongoing,":[211],"open-label":[212],"Phase":[213],"1/2":[214],"evaluate":[217,318],"safety,":[219],"tolerability,":[220],"PK,":[221,373],"patients":[228],"metastatic":[230,232,361],"RCC,":[231,360],"or":[233,236,255,280,308,362,365],"relapsed":[234,363],"NPC,":[235,364],"advanced":[237,366],"relapsed/refractory":[238,367],"NHL.":[239,260],"Patients":[240,261],"must":[241,262],"have":[242,264],"measurable":[243],"disease":[244,304],"per":[245],"Response":[247],"Evaluation":[248],"Criteria":[249],"Solid":[251],"Tumors":[252],"(RECIST)":[253],"1.1":[254],"Lugano":[257],"Classification":[258],"previously":[265],"received":[266],"therapies":[267],"known":[268],"confer":[270],"clinical":[271],"benefit":[272],"unless":[273],"considered":[274],"ineligible,":[275],"refused":[276],"by":[277,289],"patient,":[279],"available":[282],"region.":[285],"given":[288],"intravenous":[290],"infusion":[291],"Day":[293],"21-day":[297],"cycle":[298],"may":[301],"continue":[302],"until":[303],"progression,":[305],"unacceptable":[306],"toxicity,":[307],"other":[309],"reason":[310],"discontinuation.":[312],"The":[313,382],"objectives":[315],"are":[316],"safety":[320],"tolerability":[322],"identify":[327],"maximum":[329],"tolerated":[330],"dose,":[331],"if":[332],"reached,":[333],"recommended":[335],"phase":[336],"2":[337,344],"dose":[338],"(RP2D).":[339],"This":[340],"consists":[342],"parts,":[345],"Part":[346,353],"A:":[347],"dose-escalation":[348],"dose-level":[350],"expansion,":[351],"B:":[354],"3":[355],"tumor-specific":[356],"expansion":[357],"cohorts":[358],"(metastatic":[359],"NHL)":[368],"treated":[369],"at":[370,387],"RP2D.":[372],"immunogenicity,":[374],"will":[378],"be":[380],"evaluated.":[381],"currently":[385],"enrolling":[386],"sites":[388],"US,":[391],"future":[393],"enrollment":[394],"China":[396],"planned":[397],"(Clinicaltrials.gov:":[398],"NCT05721222).":[399]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-08-24T00:00:00"}